Literature DB >> 18088372

Assessment of post-mortem-induced changes to the mouse brain proteome.

Stephen W Hunsucker1, Benjamin Solomon, Jeremy Gawryluk, Jonathan D Geiger, Guido N Vacano, Mark W Duncan, David Patterson.   

Abstract

This study was designed to assess the influence of high-energy head-focused microwave irradiation and the post-mortem interval on measurements of the mouse brain proteome. Difference gel electrophoresis was used to compare mouse brain protein levels in animals killed by decapitation, where the tissue was held at 25 degrees C for selected time intervals post-mortem, and by high-energy head-focused microwave irradiation followed by immediate resection. Microwave-mediated killing was used because it comprehensively snap-inactivates enzymes while largely retaining brain cytoarchitecture. Of the 912 protein spots common to at least eight of 10 gels analyzed, 35 (3.8%) showed significant differences in levels (t-test; p < 0.05) depending on whether animals were killed by microwave irradiation or decapitation. When animals were killed by decapitation, 43 protein spots (4.7%) showed changes in levels over the post-mortem interval (anova; p < 0.05). The vast majority of the near 1000 proteins evident on a 2D gel were stable for up to 4 h. These data have important implications for studies of proteins in the brain, whether based on analysis of tissue derived from animal models or from humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18088372     DOI: 10.1111/j.1471-4159.2007.05183.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

1.  Impact of temperature dependent sampling procedures in proteomics and peptidomics--a characterization of the liver and pancreas post mortem degradome.

Authors:  Birger Scholz; Karl Sköld; Kim Kultima; Celine Fernandez; Sofia Waldemarson; Mikhail M Savitski; Marcus Söderquist; Mats Borén; Robert Stella; Per Andrén; Roman Zubarev; Peter James
Journal:  Mol Cell Proteomics       Date:  2010-01-28       Impact factor: 5.911

2.  Proteomic analysis of six- and twelve-month hippocampus and cerebellum in a murine Down syndrome model.

Authors:  Guido N Vacano; David S Gibson; Abdullah Arif Turjoman; Jeremy W Gawryluk; Jonathan D Geiger; Mark Duncan; David Patterson
Journal:  Neurobiol Aging       Date:  2017-11-26       Impact factor: 4.673

3.  Closing the gap between brain banks and proteomics to advance the study of neurodegenerative diseases.

Authors:  Renata Elaine Paraizo Leite; Lea Tenenholz Grinberg
Journal:  Proteomics Clin Appl       Date:  2015-09-08       Impact factor: 3.494

4.  Plasma proteomics of differential outcome to long-term therapy in children with idiopathic pulmonary arterial hypertension.

Authors:  Michael E Yeager; Kelley L Colvin; Allen D Everett; Kurt R Stenmark; D Dunbar Ivy
Journal:  Proteomics Clin Appl       Date:  2012-06       Impact factor: 3.494

Review 5.  The use of neuroproteomics in drug abuse research.

Authors:  Melinda E Lull; Willard M Freeman; Heather D VanGuilder; Kent E Vrana
Journal:  Drug Alcohol Depend       Date:  2009-11-17       Impact factor: 4.492

6.  In situ 3D magnetic resonance metabolic imaging of microwave-irradiated rodent brain: a new tool for metabolomics research.

Authors:  Robin A de Graaf; Golam M I Chowdhury; Peter B Brown; Douglas L Rothman; Kevin L Behar
Journal:  J Neurochem       Date:  2009-02-07       Impact factor: 5.372

Review 7.  Molecular genetic analysis of Down syndrome.

Authors:  David Patterson
Journal:  Hum Genet       Date:  2009-06-13       Impact factor: 4.132

8.  The post-synaptic density of human postmortem brain tissues: an experimental study paradigm for neuropsychiatric illnesses.

Authors:  Chang-Gyu Hahn; Anamika Banerjee; Matthew L Macdonald; Dan-Sung Cho; Joshua Kamins; Zhiping Nie; Karin E Borgmann-Winter; Tilo Grosser; Angel Pizarro; Eugene Ciccimaro; Steven E Arnold; Hoau-Yan Wang; Ian A Blair
Journal:  PLoS One       Date:  2009-04-16       Impact factor: 3.752

9.  Identification of peptide ligands for targeting to the blood-brain barrier.

Authors:  Inge van Rooy; Serpil Cakir-Tascioglu; Pierre-Olivier Couraud; Ignacio A Romero; Babette Weksler; Gert Storm; Wim E Hennink; Raymond M Schiffelers; Enrico Mastrobattista
Journal:  Pharm Res       Date:  2010-02-17       Impact factor: 4.200

10.  Mice over-expressing the myocardial creatine transporter develop progressive heart failure and show decreased glycolytic capacity.

Authors:  Darci Phillips; Michiel Ten Hove; Jurgen E Schneider; Colin O Wu; Liam Sebag-Montefiore; Angel M Aponte; Craig A Lygate; Julie Wallis; Kieran Clarke; Hugh Watkins; Robert S Balaban; Stefan Neubauer
Journal:  J Mol Cell Cardiol       Date:  2009-11-11       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.